scholarly journals A quantitative global proteomics approach to understanding the functional pathways dysregulated in the spermatozoa of asthenozoospermic testicular cancer patients

Andrology ◽  
2019 ◽  
Author(s):  
M. K. Panner Selvam ◽  
A. Agarwal ◽  
P. N. Pushparaj
2021 ◽  
Author(s):  
Yueqiong Ni ◽  
Zoltan Lohinai ◽  
Yoshitaro Heshiki ◽  
Balazs Dome ◽  
Judit Moldvay ◽  
...  

AbstractCachexia is associated with decreased survival in cancer patients and has a prevalence of up to 80%. The etiology of cachexia is poorly understood, and limited treatment options exist. Here, we investigated the role of the human gut microbiome in cachexia by integrating shotgun metagenomics and plasma metabolomics of 31 lung cancer patients. The cachexia group showed significant differences in the gut microbial composition, functional pathways of the metagenome, and the related plasma metabolites compared to non-cachectic patients. Branched-chain amino acids (BCAAs), methylhistamine, and vitamins were significantly depleted in the plasma of cachexia patients, which was also reflected in the depletion of relevant gut microbiota functional pathways. The enrichment of BCAAs and 3-oxocholic acid in non-cachectic patients were positively correlated with gut microbial species Prevotella copri and Lactobacillus gasseri, respectively. Furthermore, the gut microbiota capacity for lipopolysaccharides biosynthesis was significantly enriched in cachectic patients. The involvement of the gut microbiome in cachexia was further observed in a high-performance machine learning model using solely gut microbial features. Our study demonstrates the links between cachectic host metabolism and specific gut microbial species and functions in a clinical setting, suggesting that the gut microbiota could have an influence on cachexia with possible therapeutic applications.


1991 ◽  
Vol 19 (2) ◽  
pp. 125-131 ◽  
Author(s):  
S.D. Fosså ◽  
J.E. Melvik ◽  
N.O. Juul ◽  
E.O. Pettersen ◽  
Ø. Åmellem ◽  
...  

2006 ◽  
Vol 21 (11) ◽  
pp. 2882-2889 ◽  
Author(s):  
Loredana Gandini ◽  
Paolo Sgrò ◽  
Francesco Lombardo ◽  
Donatella Paoli ◽  
Franco Culasso ◽  
...  

1997 ◽  
Vol 78 (2) ◽  
pp. 120-123 ◽  
Author(s):  
R.H. Martin ◽  
S. Ernst ◽  
A. Rademaker ◽  
L. Barclay ◽  
E. Ko ◽  
...  

Author(s):  
Ming-Feng Hou ◽  
Fu Ou-Yang ◽  
Chung-Liang Li ◽  
Fang-Ming Chen ◽  
Chieh-Han Chuang ◽  
...  

AbstractIn Western countries, breast cancer tends to occur in older postmenopausal women. However, in Asian countries, the proportion of younger premenopausal breast cancer patients is increasing. Increasing evidence suggests that the gut microbiota plays a critical role in breast cancer. However, studies on the gut microbiota in the context of breast cancer have mainly focused on postmenopausal breast cancer. Little is known about the gut microbiota in the context of premenopausal breast cancer. This study aimed to comprehensively explore the gut microbial profiles, diagnostic value, and functional pathways in premenopausal breast cancer patients. Here, we analyzed 267 breast cancer patients with different menopausal statuses and age-matched female controls. The α-diversity was significantly reduced in premenopausal breast cancer patients, and the β-diversity differed significantly between breast cancer patients and controls. By performing multiple analyses and classification, 14 microbial markers were identified in the different menopausal statuses of breast cancer. Bacteroides fragilis was specifically found in young women of premenopausal statuses and Klebsiella pneumoniae in older women of postmenopausal statuses. In addition, menopausal-specific microbial markers could exhibit excellent discriminatory ability in distinguishing breast cancer patients from controls. Finally, the functional pathways differed between breast cancer patients and controls. Our findings provide the first evidence that the gut microbiota in premenopausal breast cancer patients differs from that in postmenopausal breast cancer patients and shed light on menopausal-specific microbial markers for diagnosis and investigation, ultimately providing a noninvasive approach for breast cancer detection and a novel strategy for preventing premenopausal breast cancer.


2021 ◽  
Vol 206 (Supplement 3) ◽  
Author(s):  
Aisha Siebert ◽  
Jake Miller ◽  
Evan Panken ◽  
Gregory Auffenberg ◽  
Richard Fantus ◽  
...  

1994 ◽  
pp. 223-233
Author(s):  
Nicholas J. Vogelzang ◽  
Amy M. Fremgen ◽  
Patrick D. Guinan ◽  
Joan S. Chmiel ◽  
JoAnne L. Sylvester ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document